Literature DB >> 19655134

Individualised dosing of amikacin in neonates.

Catherine M T Sherwin, Roland S Broadbent, Natalie J Medlicott, David M Reith.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19655134     DOI： 10.1007/s00228-009-0691-y

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  4 in total

1.  Effects of co-administration of ibuprofen-lysine on the pharmacokinetics of amikacin in preterm infants during the first days of life.

Authors:  K Allegaert; V Cossey; J P Langhendries; G Naulaers; C Vanhole; H Devlieger; B Van Overmeire
Journal:  Biol Neonate       Date:  2004-07-07

2.  Individualised dosing of amikacin in neonates: a pharmacokinetic/pharmacodynamic analysis.

Authors:  Catherine M T Sherwin; Sofia Svahn; Antje Van der Linden; Roland S Broadbent; Natalie J Medlicott; David M Reith
Journal:  Eur J Clin Pharmacol       Date:  2009-03-21       Impact factor: 2.953

3.  Prime time for enzymatic creatinine methods in pediatrics.

Authors:  Christa M Cobbaert; Henk Baadenhuijsen; Cas W Weykamp
Journal:  Clin Chem       Date:  2009-01-23       Impact factor: 8.327

4.  Adaptation in neonatology of the once-daily concept of aminoglycoside administration: evaluation of a dosing chart for amikacin in an intensive care unit.

Authors:  J P Langhendries; O Battisti; J M Bertrand; A François; M Kalenga; J Darimont; E Scalais; P Wallemacq
Journal:  Biol Neonate       Date:  1998-11
  4 in total
  1 in total

1.  Developmental pharmacokinetics of piperacillin and tazobactam using plasma and dried blood spots from infants.

Authors:  Michael Cohen-Wolkowiez; Kevin M Watt; Chenguang Zhou; Barry T Bloom; Brenda Poindexter; Lisa Castro; Jamie Gao; Edmund V Capparelli; Daniel K Benjamin; P Brian Smith
Journal:  Antimicrob Agents Chemother       Date:  2014-03-10       Impact factor: 5.938
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.